Dr Magdi Saba

Dr Magdi Saba is a highly accomplished consultant cardiac electrophysiologist at St George’s University Hospital, London, with an extensive background in the diagnosis and treatment of cardiac arrhythmias. His expertise encompasses both medical and ablative therapies for atrial and ventricular arrhythmias, as well as the implantation of cardiac rhythm devices.

Recognised internationally for his contributions to the field, Dr Saba is particularly distinguished for his work in the mapping and ablation of ventricular arrhythmias. Dr Saba’s medical journey began with his graduation from Cairo University Faculty of Medicine in 1994, followed by a fellowship and MSc in cardiovascular medicine. He was appointed lecturer at Cairo University Hospitals in 1999. His training then took him to the United States, where he completed an internship at SUNY-New York and a residency in internal medicine at The George Washington University in 2002.

He pursued further specialisation with a three-year cardiology fellowship at the Ochsner Clinic in New Orleans and a fellowship in cardiac electrophysiology at Loyola University, Chicago. In 2006, Dr Saba was appointed assistant p[rofessor of medicine at the University of Maryland, Baltimore, before moving to the UK in 2010 to join St George’s University Hospital.

Dr Saba’s research focuses on advancing ventricular arrhythmia mapping and ablation strategies, and he holds a patent for a technique to pinpoint the site of origin of ventricular arrhythmias. He is a prominent figure in his field, serving as a regular faculty member at leading arrhythmia conferences and as co-director of the European Heart Rhythm Association’s Ventricular Tachycardia Course. He is also the founding chairman of the London Ventricular Tachyarrhythmia Symposium, an annual event launched in 2010, and director of the Advanced Ventricular Arrhythmia Training and Research (AVATAR) program at St George’s University Hospital.

Dr Saba’s career is defined by his dedication to improving outcomes for patients with complex arrhythmias and his commitment to advancing the field through education, research, and innovation.